Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Clear NicoDerm CQ Latest Effort Against Private Label Rivals

This article was originally published in The Tan Sheet

Executive Summary

The introduction of Clear NicoDerm CQ Patch will attract a substantial number of first-time users - especially among minority populations - to the smoking cessation category, marketer SmithKline Beecham predicted based on recent consumer research.

You may also be interested in...



SB Aquafresh 17% Sales Increase Freshens Up Second Quarter Results

"Outstanding" U.S. activity by the Aquafresh brand in the second quarter contributed to a 17% spike in worldwide sales for the line and an 8% rise in global oral care sales to $255 mil., SmithKline Beecham CEO Jean-Paul Garnier, PhD, announced during a July 25 conference call.

SB Aquafresh 17% Sales Increase Freshens Up Second Quarter Results

"Outstanding" U.S. activity by the Aquafresh brand in the second quarter contributed to a 17% spike in worldwide sales for the line and an 8% rise in global oral care sales to $255 mil., SmithKline Beecham CEO Jean-Paul Garnier, PhD, announced during a July 25 conference call.

SB Aquafresh 17% Sales Increase Freshens Up Second Quarter Results

"Outstanding" U.S. activity by the Aquafresh brand in the second quarter contributed to a 17% spike in worldwide sales for the line and an 8% rise in global oral care sales to $255 mil., SmithKline Beecham CEO Jean-Paul Garnier, PhD, announced during a July 25 conference call.

Related Content

Topics

UsernamePublicRestriction

Register

PS091133

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel